Plexus Capital and 424 Capital Invest in VaLogic Bio
September 19, 2023
Plexus Capital and 424 Capital announced an investment in VaLogic Bio, a Frederick, Maryland-based provider of GMP compliance software and life-sciences laboratory services. The capital will support VaLogic’s continued growth of its facility monitoring SaaS and professional compliance services for FDA-regulated clients.
- Buyers
- Plexus Capital, LLC, 424 Capital
- Targets
- VaLogic Bio
- Industry
- Healthcare Services
- Location
- Maryland, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
424 Capital Makes Strategic Investment in VaLogic
November 29, 2023
Healthcare Services
424 Capital completed a significant investment in VaLogic, a Frederick, Maryland-based provider of GMP/GLP compliance software and life-science facility services. The capital will support VaLogic's growth plans—expanding services, markets and customer reach—while enabling pharmaceutical and biotechnology clients to focus on R&D and manufacturing with validated compliance tools (including VaLogic's LogiPoint SaaS).
-
VaLogic Bio (424 Capital) Acquires Facility Logix
September 13, 2024
Healthcare Services
VaLogic Bio, a platform company of private equity firm 424 Capital, has acquired Facility Logix, a Burtonsville, Maryland-based firm specializing in planning, development, and project management for life-sciences facilities. The deal is an add-on acquisition intended to expand VaLogic Bio's service capabilities and build a full-service outsourced solutions platform for life sciences facility design, CQV, environmental monitoring, and ongoing compliance.
-
VaLogic Bio Acquires Superior Laboratory Services, Inc.
August 1, 2024
Healthcare Services
VaLogic Bio, a Frederick, Maryland–based provider of GMP compliance and laboratory technology solutions, has acquired Superior Laboratory Services, Inc. (SLSI), a Pasadena, Texas lab design, construction and certification firm. The acquisition adds SLSI's two decades of laboratory design and USP/pharmaceutical laboratory expertise to VaLogic's service offerings and will keep the Pasadena office operational under VaLogic ownership.
-
Ampersand Capital Partners Makes Growth Investment in Vibalogics GmbH
May 29, 2019
Biotechnology
Ampersand Capital Partners has made a growth equity investment in Vibalogics GmbH, a German CDMO specializing in development and GMP manufacturing of complex viral products. The investment will fund expansion of Vibalogics' process development and manufacturing capabilities and support broader growth in the U.S. and European markets.
-
Northrim Horizon Makes Strategic Growth Investment in VLogic Systems
June 12, 2024
Cloud & SaaS
Northrim Horizon, a private equity firm, has made a strategic growth investment in VLogic Systems, a Concord, Massachusetts–based developer of a FedRAMP-authorized IWMS and Connected Portfolio Intelligence Platform (VLogicFM). The investment will support VLogic's product expansion, continued growth into federal and commercial markets, and scale its sales and hiring plans while management remains in place.
-
Growth Capital Partners (GCP) Makes Minority Investment in CubeLogic
June 26, 2020
Software
Growth Capital Partners (GCP) has made a minority growth investment in CubeLogic as the ninth investment from GCP Fund IV. CubeLogic, a London-based provider of enterprise risk management software for the energy, commodities and financial markets, will use the capital to accelerate international expansion, product development and support its ambitious growth plans.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.